Conjugation

The meningococcal vaccine market is diverse and complex with regional variations in serogroup distribution and significant use outside of routine immunization. The global supply of conjugate MenACWY is insufficient to meet demand growth triggered by rising incidence of serogroups C and W and the limited availability of polysaccharide vaccines. Low and middle income countries struggle for access to multivalent and conjugate vaccines due to limited global supply and high cost for conjugate vaccines. With this in consideration, our NMCV-4 program continues to be in development through self-funding.

Conjugation

The meningococcal vaccine market is diverse and complex with regional variations in serogroup distribution and significant use outside of routine immunization. The global supply of conjugate MenACWY is insufficient to meet demand growth triggered by rising incidence of serogroups C and W and the limited availability of polysaccharide vaccines. Low and middle income countries struggle for access to multivalent and conjugate vaccines due to limited global supply and high cost for conjugate vaccines. With this in consideration, our NMCV-4 program continues to be in development through self-funding.

Pentavalent vaccine protects against five major diseases

1. Diphtheria
2. Tetanus
3. Pertussis (Whooping Cough)
4. Haemophilus Influenza Type B
5. Polio

Conjugation

InventVacc is committed to supporting low-income countries with expectations of a higher quality of life

Hexavalent vaccine protects against six major diseases

1. Diphtheria
2. Tetanus
3. Pertussis (Whooping Cough)
4. Haemophilus Influenza Type B
5. Polio
6. Hepatitis B

Confidential Information

Confidential Information

Conjugation

The value of the pneumococcal vaccines market will steadily grow over from USD 7.2 billion (2019) to over USD 11 billion by 2030 representing the second largest segment of the vaccine industry (measured by dollar volume).